Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M N Saleh

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Journal of Clinical Immunology|March 1, 1992
Frequent anti-V-region immune response to mouse B72.3 monoclonal antibodyM B Khazaeli, M N Saleh, T Liu, et al.
Developmental Neurorehabilitation|October 19, 2007
Actual vs. best practices for young children with cerebral palsy: a survey of paediatric occupational therapists and physical therapists in Quebec, CanadaM N Saleh, N Korner-Bitensky, L Snider, et al.
Journal of the National Cancer Institute|August 17, 1988
Phase I trial of multiple large doses of murine monoclonal antibody CO17-1A. I. Clinical aspectsA F LoBuglio, M N Saleh, J Lee, et al.
Blood|January 1, 1987
Platelet surface-bound IgG in patients with immune and nonimmune thrombocytopeniaW S Court, J M Bozeman, S J Soong, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 2, 2001
A pilot trial of Vitaxin, a humanized anti-vitronectin receptor (anti alpha v beta 3) antibody in patients with metastatic cancerJ A Posey, M B Khazaeli, A DelGrosso, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1995
Phase I trial of an anti-CD19 deglycosylated ricin A chain immunotoxin in non-Hodgkin's lymphoma: effect of an intensive schedule of administrationR M Conry, M B Khazaeli, M N Saleh, et al.
Journal of the National Cancer Institute|August 17, 1988
Phase I trial of multiple large doses of murine monoclonal antibody CO17-1A. II. Pharmacokinetics and immune responseM B Khazaeli, M N Saleh, R H Wheeler, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 28, 1998
Immunologic response to the dual murine anti-Id vaccine Melimmune-1 and Melimmune-2 in patients with high-risk melanoma without evidence of systemic diseaseM N Saleh, D Y Lalisan, M W Pride, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1990
A phase II trial of murine monoclonal antibody 17-1A and interferon-gamma: clinical and immunological dataM N Saleh, A F LoBuglio, R H Wheeler, et al.
Arthritis and Rheumatism|August 1, 1990
Intravenous immunoglobulin therapy in systemic lupus erythematosus-associated thrombocytopeniaW P Maier, D S Gordon, R F Howard, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Journal of Clinical Immunology|March 1, 1992
Frequent anti-V-region immune response to mouse B72.3 monoclonal antibodyM B Khazaeli, M N Saleh, T Liu, et al.
Developmental Neurorehabilitation|October 19, 2007
Actual vs. best practices for young children with cerebral palsy: a survey of paediatric occupational therapists and physical therapists in Quebec, CanadaM N Saleh, N Korner-Bitensky, L Snider, et al.
Journal of the National Cancer Institute|August 17, 1988
Phase I trial of multiple large doses of murine monoclonal antibody CO17-1A. I. Clinical aspectsA F LoBuglio, M N Saleh, J Lee, et al.
Blood|January 1, 1987
Platelet surface-bound IgG in patients with immune and nonimmune thrombocytopeniaW S Court, J M Bozeman, S J Soong, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 2, 2001
A pilot trial of Vitaxin, a humanized anti-vitronectin receptor (anti alpha v beta 3) antibody in patients with metastatic cancerJ A Posey, M B Khazaeli, A DelGrosso, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1995
Phase I trial of an anti-CD19 deglycosylated ricin A chain immunotoxin in non-Hodgkin's lymphoma: effect of an intensive schedule of administrationR M Conry, M B Khazaeli, M N Saleh, et al.
Journal of the National Cancer Institute|August 17, 1988
Phase I trial of multiple large doses of murine monoclonal antibody CO17-1A. II. Pharmacokinetics and immune responseM B Khazaeli, M N Saleh, R H Wheeler, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 28, 1998
Immunologic response to the dual murine anti-Id vaccine Melimmune-1 and Melimmune-2 in patients with high-risk melanoma without evidence of systemic diseaseM N Saleh, D Y Lalisan, M W Pride, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1990
A phase II trial of murine monoclonal antibody 17-1A and interferon-gamma: clinical and immunological dataM N Saleh, A F LoBuglio, R H Wheeler, et al.
Arthritis and Rheumatism|August 1, 1990
Intravenous immunoglobulin therapy in systemic lupus erythematosus-associated thrombocytopeniaW P Maier, D S Gordon, R F Howard, et al.
Pageof 5